Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

International Journal of Molecular Medicine

Volumn 31, Issue 5, 2013, Pages 1011-1016

  D'Amico, Fabio ^a   Skarmoutsou, Evangelia ^a   Quaderno, Giuseppe ^a   Malaponte, Grazia ^a   Corte, Carmelo La ^b   Scibili, Giuseppe ^c   D'Agate, Gabriella ^c   Scollo, Paolo ^c   Fraggetta, Filippo ^b   Spandidos, Demetrios A ^d   Mazzarino, Maria Clorinda ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Pathology Unit   (Italy)

^c CANNIZZARO HOSPITAL   (Italy)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

CD133; Endometriosis; Endometrium; Immunohistochemistry; Osteopontin; Quantitative real time RT PCR

Indexed keywords

CD133 ANTIGEN; MESSENGER RNA; OSTEOPONTIN; PROMININ 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; DEMOGRAPHY; ENDOMETRIOSIS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; OSTEOPONTIN; PEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84876159634     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1325     Document Type: Article

References (32)

1. de Ziegler D, Borghese B and Chapron C: Endometriosis and infertility: pathophysiology and management. Lancet 376: 730-738, 2012.
2. Swiersz LM: Role of endometriosis in cancer and tumor development. Ann NY Acad Sci 955: 281-292, 2002.
3. Borghese B, Mondon F, Noël JC, Fayt I, Mignot TM, Vaiman D and Chapron C: Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol 22: 2557-2562, 2008.
4. Anborgh PH, Mutrie JC, Tuck AB and Chambers AF: Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med 14: 2037-2044, 2010.
5. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM and Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 95: 713-724, 1995.
6. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR and Lessey BA: Osteopontin and its receptor alphav beta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 86: 4991-5000, 2001.
7. Odagiri K, Konno R, Fujiwara H, Netsu S, Ohwada M, Shibahara H and Suzuki M: Immunohistochemical study of osteopontin and L-selectin in a rat endometriosis model and in human endometriosis. Fertil Steril 88: 1207-1211, 2007.
8. Cho S, Ahn YS, Choi YS, Seo SK, Nam A, Kim HY, Kim JH, Park KH, Cho DJ and Lee BS: Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis. Am J Reprod Immunol 61: 286-293, 2009.
9. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA and Giudice LC: Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148: 3814-3826, 2007.
10. Wei Q, St Clair JB, Fu T, Stratton P and Nieman LK: Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril 91: 1686-1691, 2009.
11. Götte M, Wolf M, Staebler A, Buchweitz O, Kelsch R, Schüring AN and Kiesel L: Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol 215: 317-329, 2008.
12. Maruyama T and Yoshimura Y: Stem cell theory for the pathogenesis of endometriosis. Front Biosci (Elite Ed) 4: 2854-2863, 2012.
13. Corbeil D, Karbanová J, Fargeas CA and Jászai J: Prominin-1 (CD133): molecular and cellular features across species. Adv Exp Med Biol 777: 3-24, 2013.
14. Schwab KE, Hutchinson P and Gargett CE: Identification of surface markers for prospective isolation of human endometrial stromal colony-forming cells. Hum Reprod 23: 934-943, 2008.
15. Sasson IE and Taylor HS: Stem cells and the pathogenesis of endometriosis. Ann NY Acad Sci 1127: 106-115, 2008.
16. Wang Y, Yan W, Lu X, Qian C, Zhang J, Li P, Shi L, Zhao P, Fu Z, Pu P, Kang C, Jiang T, Liu N and You Y: Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol 90: 642-648, 2011.
17. Yu M, Liu Q, Yi K, Wu L and Tan X: Effects of osteopontin on functional activity of late endothelial progenitor cells. J Cell Biochem 112: 1730-1736, 2011.
18. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67: 817-821, 1997.
19. Eyster KM, Klinkova O, Kennedy V and Hansen KA: Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 88: 1505-1533, 2007.
20. Casals G, Ordi J, Creus M, Fábregues F, Carmona F, Casamitjana R and Balasch J: Expression pattern of osteopontin and αvβ3 integrin during the implantation window in infertile patients with early stages of endometriosis. Hum Reprod 27: 805-813, 2012.
21. Flores I, Rivera E, Ruiz LA, Santiago OI, Vernon MW and Appleyard CB: Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril 87: 1180-1199, 2007.
22. Konno R, Fujiwara H, Netsu S, Odagiri K, Shimane M, Nomura H and Suzuki M: Gene expression profiling of the rat endometriosis model. Am J Reprod Immunol 58: 330-343, 2007
23. Chan RW, Ng EH and Yeung WS: Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. Am J Pathol 178: 2832-2844, 2011.
24. Masuda H, Matsuzaki Y, Hiratsu E, Ono M, Nagashima T, Kajitani T, Arase T, Oda H, Uchida H, Asada H, Ito M, Yoshimura Y, Maruyama T and Okano H: Stem cell-like properties of the endometrial side population: implication in endometrial regeneration. PLoS One 5: e10387, 2010.
25. Leen LL, Filipe C, Billon A, Garmy-Susini B, Jalvy S, Robbesyn F, Daret D, Allières C, Rittling SR, Werner N, Nickenig G, Deutsch U, Duplàa C, Dufourcq P, Lenfant F, Desgranges C, Arnal JF and Gadeau AP: Estrogen-stimulated endothelial repair requires osteopontin. Arterioscler Thromb Vasc Biol 28: 2131-2136, 2008.
26. Stier S, Ko Y, Forkert R, Lutz C, Neuhaus T, Grunewald E, Cheng T, Dombkowski D, Calvi LM, Rittling SR and Scadden DT: Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 201: 1781-1791, 2005.
27. Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ and Haylock DN: Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106: 1232-1239, 2005.
28. Lee JL, Wang MJ, Sudhir PR and Chen JY: CD44 engagement promotes matrix derived survival through the CD44-SRC2011;integrin axis in lipid rafts. Mol Cell Biol 28: 5710-5723, 2008.
29. Jacobson K and Dietrich C: Looking at lipid rafts? Trends Cell Biol 9: 87-91, 1999.
30. Bauer N, Fonseca AV, Florek M, Freund D, Jászai J, Bornhäuser M, Fargeas CA and Corbeil D: New insights into the cell biology of hematopoietic progenitors by studying Prominin-1 (CD133). Cells Tissues Organs 188: 127-138, 2008.
31. Kyo S, Maida Y and Inoue M: Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions. Cancer Lett 308: 123-133, 2011.
32. Kokcu A: Relationship between endometriosis and cancer from current perspective. Arch Gynecol Obstet 284: 1473-1479, 2011.